Literature DB >> 1801657

Psoriasis and psoriasiform eruptions associated with propranolol--the role of an immunological mechanism.

S Halevy1, E Livni.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1801657     DOI: 10.1007/BF00371785

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


× No keyword cloud information.
  13 in total

1.  Untoward effects associated with practolol: demonstration of antibody binding to epithelial tissue.

Authors:  H E Amos; W D Brigden; R A McKerron
Journal:  Br Med J       Date:  1975-03-15

2.  DELAYED HYPERSENSITIVITY IN VITRO. I. THE SPECIFICITY OF INHIBITION OF CELL MIGRATION BY ANTIGENS.

Authors:  J R DAVID; S AL-ASKARI; H S LAWRENCE; L THOMAS
Journal:  J Immunol       Date:  1964-08       Impact factor: 5.422

3.  Psoriasiform eruption induced by propranolol.

Authors:  S Halevy; E J Feuerman
Journal:  Cutis       Date:  1979-07

4.  Cutaneous and ocular reactions to practolol.

Authors:  R H Felix; F A Ive; M G Dahl
Journal:  Br Med J       Date:  1974-11-09

5.  beta-Blockers, autoimmunity, and rashes.

Authors:  R Staughton; R Sutton; M Farrell
Journal:  Lancet       Date:  1980-09-13       Impact factor: 79.321

6.  The appearance of macrophage migration-inhibition factor in drug reactions.

Authors:  E Livni; S Halevy; B Stahl; H Joshua
Journal:  J Allergy Clin Immunol       Date:  1987-12       Impact factor: 10.793

7.  Concurrent cell-mediated immunity and immediate hypersensitivity in animal model.

Authors:  R Wolf; E Livni; H Joshua
Journal:  Ann Allergy       Date:  1984-04

8.  Aggravation of psoriasis and occurrence of psoriasiform cutaneous eruptions induced by practolol (Eraldin).

Authors:  J Sondergaard; S Wadskov; H A Jensen; H I Mikkelsen
Journal:  Acta Derm Venereol       Date:  1976       Impact factor: 4.437

9.  Systemic lupus erythematosus syndrome induced by practolol.

Authors:  E B Raftery; A M Denman
Journal:  Br Med J       Date:  1973-05-26

10.  Psoriasis provoked by beta-blocking agents.

Authors:  N Arntzen; G Kavli; G Volden
Journal:  Acta Derm Venereol       Date:  1984       Impact factor: 4.437

View more
  4 in total

1.  Drug-provoked psoriasis: is it drug induced or drug aggravated?: understanding pathophysiology and clinical relevance.

Authors:  Grace K Kim; James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2010-01

Review 2.  Beta adrenergic receptors in keratinocytes.

Authors:  Raja K Sivamani; Susanne T Lam; R Rivkah Isseroff
Journal:  Dermatol Clin       Date:  2007-10       Impact factor: 3.478

Review 3.  The role of xenobiotics in triggering psoriasis.

Authors:  Jasna Grželj; Marija Sollner Dolenc
Journal:  Arch Toxicol       Date:  2020-08-24       Impact factor: 5.153

Review 4.  Cutaneous Adverse Effects of Neurologic Medications.

Authors:  Eman Bahrani; Chloe E Nunneley; Sylvia Hsu; Joseph S Kass
Journal:  CNS Drugs       Date:  2016-03       Impact factor: 6.497

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.